Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-22

Clinical Trial Update: Kinematic-based BoNT-A Injections for Bilateral ET [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for kinematic-based botulinum toxin A injections to treat Essential Tremor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Western University, Canada | Conditions: Essential Tremor | Phase 2 | Status: UNKNOWN